# MGE Energy Inc: financial statements, quarterly

MGEE · Nasdaq · CIK 1161728 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mgee.md) · [Financials](/companies/mgee/financials.md) · [Filings](/companies/mgee/filings.md) · [Insiders](/companies/mgee/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mgee/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating income | $m | [38.4](/filings/0000950170-24-092427.md) | [43.8](/filings/0000950170-24-121952.md) | [24.2 d](/filings/0001193125-26-067036.md) | [40.7](/filings/0000950170-25-065302.md) | [29.7](/filings/0000950170-25-103668.md) | [48.1](/filings/0001193125-25-266253.md) | [27.6 d](/filings/0001193125-26-067036.md) | [52.9](/filings/0001193125-26-205678.md) | [34.2](/filings/0000950170-25-103668.md) | [51.1](/filings/0001193125-25-266253.md) | [32.5 d](/filings/0001193125-26-067036.md) | [53.2](/filings/0001193125-26-205678.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [6.9](/filings/0000950170-24-092427.md) | [8.8](/filings/0000950170-24-121952.md) | [5.3 d](/filings/0001193125-26-067036.md) | [2.8](/filings/0000950170-25-065302.md) | [1.5](/filings/0000950170-25-103668.md) | [3.6](/filings/0001193125-25-266253.md) | [2.7 d](/filings/0001193125-26-067036.md) | [6.3](/filings/0001193125-26-205678.md) | [3.0](/filings/0000950170-25-103668.md) | [7.8](/filings/0001193125-25-266253.md) | [3.7 d](/filings/0001193125-26-067036.md) | [5.9](/filings/0001193125-26-205678.md) |
| Net income | $m | [28.7](/filings/0000950170-24-092427.md) | [37.9](/filings/0000950170-24-121952.md) | [20.1 d](/filings/0001193125-26-067036.md) | [33.8](/filings/0000950170-25-065302.md) | [23.8](/filings/0000950170-25-103668.md) | [40.9](/filings/0001193125-25-266253.md) | [22.0 d](/filings/0001193125-26-067036.md) | [41.6](/filings/0001193125-26-205678.md) | [26.5](/filings/0000950170-25-103668.md) | [44.5](/filings/0001193125-25-266253.md) | [23.3 d](/filings/0001193125-26-067036.md) | [48.5](/filings/0001193125-26-205678.md) |
| Diluted EPS | $ per share | [0.79](/filings/0000950170-24-092427.md) | [1.05](/filings/0000950170-24-121952.md) | not reported | [0.93](/filings/0000950170-25-065302.md) | [0.66](/filings/0000950170-25-103668.md) | [1.13](/filings/0001193125-25-266253.md) | not reported | [1.14](/filings/0001193125-26-205678.md) | [0.72](/filings/0000950170-25-103668.md) | [1.22](/filings/0001193125-25-266253.md) | not reported | [1.32](/filings/0001193125-26-205678.md) |
| Basic EPS | $ per share | [0.79](/filings/0000950170-24-092427.md) | [1.05](/filings/0000950170-24-121952.md) | not reported | [0.93](/filings/0000950170-25-065302.md) | [0.66](/filings/0000950170-25-103668.md) | [1.13](/filings/0001193125-25-266253.md) | not reported | [1.14](/filings/0001193125-26-205678.md) | [0.73](/filings/0000950170-25-103668.md) | [1.22](/filings/0001193125-25-266253.md) | not reported | [1.32](/filings/0001193125-26-205678.md) |

- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [16.5](/filings/0000950170-23-037779.md) | [11.3](/filings/0000950170-23-057851.md) | [11.1](/filings/0000950170-25-026262.md) | [16.7](/filings/0000950170-24-055186.md) | [16.3](/filings/0000950170-24-092427.md) | [14.9](/filings/0000950170-24-121952.md) | [21.3](/filings/0001193125-26-067036.md) | [35.3](/filings/0000950170-25-065302.md) | [10.6](/filings/0000950170-25-103668.md) | [10.1](/filings/0001193125-25-266253.md) | [5.7](/filings/0001193125-26-205678.md) | [9.5](/filings/0001193125-26-205678.md) |
| Current assets | $m | [223](/filings/0000950170-23-037779.md) | [216](/filings/0000950170-23-057851.md) | [238](/filings/0000950170-25-026262.md) | [222](/filings/0000950170-24-055186.md) | [222](/filings/0000950170-24-092427.md) | [210](/filings/0000950170-24-121952.md) | [227](/filings/0001193125-26-067036.md) | [222](/filings/0000950170-25-065302.md) | [198](/filings/0000950170-25-103668.md) | [195](/filings/0001193125-25-266253.md) | [229](/filings/0001193125-26-205678.md) | [211](/filings/0001193125-26-205678.md) |
| Total assets | $m | [2,560](/filings/0000950170-23-037779.md) | [2,591](/filings/0000950170-23-057851.md) | [2,675](/filings/0000950170-25-026262.md) | [2,674](/filings/0000950170-24-055186.md) | [2,725](/filings/0000950170-24-092427.md) | [2,749](/filings/0000950170-24-121952.md) | [2,828](/filings/0001193125-26-067036.md) | [2,841](/filings/0000950170-25-065302.md) | [2,861](/filings/0000950170-25-103668.md) | [2,991](/filings/0001193125-25-266253.md) | [3,155](/filings/0001193125-26-205678.md) | [3,186](/filings/0001193125-26-205678.md) |
| Current liabilities | $m | [159](/filings/0000950170-23-037779.md) | [123](/filings/0000950170-23-057851.md) | [157](/filings/0000950170-25-026262.md) | [140](/filings/0000950170-24-055186.md) | [168](/filings/0000950170-24-092427.md) | [150](/filings/0000950170-24-121952.md) | [126](/filings/0001193125-26-067036.md) | [108](/filings/0000950170-25-065302.md) | [110](/filings/0000950170-25-103668.md) | [215](/filings/0001193125-25-266253.md) | [297](/filings/0001193125-26-205678.md) | [183](/filings/0001193125-26-205678.md) |
| Long-term debt | $m | [652](/filings/0000950170-23-037779.md) | [690](/filings/0000950170-23-057851.md) | [719](/filings/0000950170-25-026262.md) | [718](/filings/0000950170-24-055186.md) | [716](/filings/0000950170-24-092427.md) | [715](/filings/0000950170-24-121952.md) | [764](/filings/0001193125-26-067036.md) | [762](/filings/0000950170-25-065302.md) | [761](/filings/0000950170-25-103668.md) | [745](/filings/0001193125-25-266253.md) | [792](/filings/0001193125-26-205678.md) | [880](/filings/0001193125-26-205678.md) |
| Current portion of debt | $m | [35.1](/filings/0000950170-23-037779.md) | [5.1](/filings/0000950170-23-057851.md) | [5.1](/filings/0000950170-25-026262.md) | [5.2](/filings/0000950170-24-055186.md) | [5.2](/filings/0000950170-24-092427.md) | [5.3](/filings/0000950170-24-121952.md) | [5.3](/filings/0001193125-26-067036.md) | [5.3](/filings/0000950170-25-065302.md) | [5.4](/filings/0000950170-25-103668.md) | [20.4](/filings/0001193125-25-266253.md) | [21.6](/filings/0001193125-26-205678.md) | [20.5](/filings/0001193125-26-205678.md) |
| Short-term borrowings | $m | [42.0](/filings/0000950170-23-037779.md) | [22.0](/filings/0000950170-23-057851.md) | [38.0](/filings/0000950170-25-026262.md) | [41.0](/filings/0000950170-24-055186.md) | [59.8](/filings/0000950170-24-092427.md) | [48.5](/filings/0000950170-24-121952.md) | [0.0](/filings/0001193125-26-067036.md) | not reported | [5.5](/filings/0000950170-25-103668.md) | [76.0](/filings/0001193125-25-266253.md) | [94.5](/filings/0001193125-26-205678.md) | [40.3](/filings/0001193125-26-205678.md) |
| Shareholders' equity | $m | [1,113](/filings/0000950170-24-121952.md) | [1,135](/filings/0000950170-24-121952.md) | [1,140](/filings/0001193125-26-067036.md) | [1,159](/filings/0000950170-25-103668.md) | [1,168](/filings/0001193125-25-266253.md) | [1,195](/filings/0001193125-25-266253.md) | [1,230](/filings/0001193125-26-205678.md) | [1,259](/filings/0001193125-26-205678.md) | [1,270](/filings/0001193125-25-266253.md) | [1,298](/filings/0001193125-25-266253.md) | [1,304](/filings/0001193125-26-205678.md) | [1,349](/filings/0001193125-26-205678.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [71.0 d](/filings/0000950170-24-092427.md) | [67.0 d](/filings/0000950170-24-121952.md) | [43.5 d](/filings/0001193125-26-067036.md) | [65.8](/filings/0000950170-25-065302.md) | [64.6 d](/filings/0000950170-25-103668.md) | [79.4 d](/filings/0001193125-25-266253.md) | [67.9 d](/filings/0001193125-26-067036.md) | [77.9](/filings/0001193125-26-205678.md) | [56.1 d](/filings/0000950170-25-103668.md) | [94.8 d](/filings/0001193125-25-266253.md) | [34.5 d](/filings/0001193125-26-067036.md) | [80.7](/filings/0001193125-26-205678.md) |
| Capital expenditure | $m | [60.1 d](/filings/0000950170-24-092427.md) | [42.6 d](/filings/0000950170-24-121952.md) | [71.8 d](/filings/0001193125-26-067036.md) | [44.8](/filings/0000950170-25-065302.md) | [66.9 d](/filings/0000950170-25-103668.md) | [52.4 d](/filings/0001193125-25-266253.md) | [72.9 d](/filings/0001193125-26-067036.md) | [47.7](/filings/0001193125-26-205678.md) | [64.1 d](/filings/0000950170-25-103668.md) | [144 d](/filings/0001193125-25-266253.md) | [87.6 d](/filings/0001193125-26-067036.md) | [101](/filings/0001193125-26-205678.md) |
| Dividends paid | $m | [14.7 d](/filings/0000950170-24-092427.md) | [15.5 d](/filings/0000950170-24-121952.md) | [15.5 d](/filings/0001193125-26-067036.md) | [15.5](/filings/0000950170-25-065302.md) | [15.5 d](/filings/0000950170-25-103668.md) | [16.3 d](/filings/0001193125-25-266253.md) | [16.4 d](/filings/0001193125-26-067036.md) | [16.4](/filings/0001193125-26-205678.md) | [16.4 d](/filings/0000950170-25-103668.md) | [17.4 d](/filings/0001193125-25-266253.md) | [17.4 d](/filings/0001193125-26-067036.md) | [17.4](/filings/0001193125-26-205678.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [36.2](/filings/0000950170-23-037779.md) | [36.2](/filings/0000950170-23-057851.md) | [36.2](/filings/0000950170-24-055186.md) | [36.2](/filings/0000950170-24-092427.md) | [36.2](/filings/0000950170-24-121952.md) | [36.2](/filings/0000950170-25-065302.md) | [36.2](/filings/0000950170-25-103668.md) | [36.2](/filings/0001193125-25-266253.md) | [36.5](/filings/0001193125-26-205678.md) | [36.6](/filings/0000950170-25-103668.md) | [36.6](/filings/0001193125-25-266253.md) | [36.6](/filings/0001193125-26-205678.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 36,756,422 at 2026-04-30, from the cover of the [10-Q filed 2026-05-05](/filings/0001193125-26-205678.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.